Skip to main content

COVID-19 and The Coronavirus Vaccines

Email

Send Email

Recipient(s) will receive an email with a link to 'COVID-19 and The Coronavirus Vaccines' and will have access to the topic for 7 days.

Subject: COVID-19 and The Coronavirus Vaccines

(Optional message may have a maximum of 1000 characters.)

×


The Impact of COVID-19

As of January 9, 2021: 
  • Worldwide: roughly 90 million cases and 2 million deaths (247 deaths per million people)
  • United States: 22.5 million cases and 378,000 deaths (1,140 deaths per million people)

How to Prevent Getting COVID or Spreading COVID to Others

COVID Vaccines

Vaccine Company

Pfizer

Moderna

Astra Zenaca

Approval Status:

FDA Emergency Authorization

FDA Emergency Authorization

Not authorized in US. Available in UK

Type of Vaccine:

mRNA

mRNA

Viral Vectored

Timing of Injections:

2 shots, 3 weeks apart

2 shots, 4 weeks apart

Half dose, then full dose 28 days later

Percent Effective

(8 weeks after 2nd shot)

95%

(8 weeks after 2nd shot)

94%

(8 weeks after 2nd shot)

90%

(14 days after 2nd shot)

Age Group

16 years and above

18 years and above

Not approved in US

Rate of Serious Side Effects

0.6% for vaccine

0.5% for placebo

1.5% for vaccine

1.1% for placebo

0.72% for vaccine

For updated information go to: www.cdc.gov/vaccines/covid-19

×
×